Clinical Trials Sponsored by Buda Health Center

Total 17612 results

Fuda Cancer Hospital, Guangzhou

Completed

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Lung Neoplasms
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient

Lung Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient

Liver Neoplasms

China
Bayside Health
Monash University; Bupa Aged Care Australia

Recruiting

Nurse-led Antimicrobial Stewardship Intervention to Increase Antibiotic Appropriateness in Residential Aged Care Facilities

Respiratory Tract Infections | Urinary Tract Infections | Antimicrobial Stewardship | Skin and Soft Tissue Infections

Australia
Indonesia University
Julius Center; CEEBM; Budi Kemuliaan Hospital

Unknown

Effect of Breastfeeding Optimization on Early Vascular Development (BRAVO)

Cardiovascular Diseases | Breast Feeding

Indonesia
Sunnybrook Health Sciences Centre
Juravinski Cancer Center

Active, not recruiting

Assessment of QoL and Outcomes With SBRT for RCC (AQuOS-RCC)

Renal Cell Carcinoma

Canada
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Breast Cancer

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Liver Cancer

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Mix Vaccine for Metastatic Sarcoma Patients

Metastatic Sarcoma | Reaction - Mixed Vaccine

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine

Neoplasms, Lung

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Mix Vaccine for Metastatic Kidney Cancer

Metastasis From Malignant Tumor of Kidney (Disorder) | Reaction - Mixed Vaccine

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Neoplasms, Pancreas

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells

Neoplasms, Lung

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Lung Cancer

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer (CSC)

Neoplasms,Colorectal

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Mix Vaccine for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | Reaction - Mixed Vaccine

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Neoplasms,Ovarian

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety Study of Cancer Stem Cell Vaccinie to Treat Breast Cancer (CSC)

Neoplasms, Breast

China
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Neoplasms, Liver

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

Liver Tumor | Evidence of Liver Transplantation

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer

Tongue Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

Metastatic Esophageal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Secondary Malignant Neoplasm of Liver

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Recurrent Liver Carcinoma

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

Recurrent Pharyngeal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma

Recurrent Adult Soft Tissue Sarcoma

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Intestinal Cancer

Advanced Intestinal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Pancreatic Cancer

Unresectable Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Gastric Cancer

Advanced Gastric Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors

Malignant Solid Tumour

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors

Malignant Solid Tumour

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Rituximab and NK Immunotherapy for B Lymphoma

B-cell Lymphoma Recurrent

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

Melanoma

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

Metastatic Renal Cell Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Lung Cancer

Small-cell Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

Recurrent Tongue Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer

Recurrent Breast Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Recurrent Laryngeal Cancer

China

Clinical Trials Sponsored by Buda Health Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations